Cargando…
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey
BACKGROUND: As of mid-2021, Australia’s only nationwide coronavirus disease 2019 (COVID-19) epidemic occurred in the first 6 months of the pandemic. Subsequently, there has been limited transmission in most states and territories. Understanding community spread during the first wave was hampered by...
Autores principales: | Vette, Kaitlyn M, Machalek, Dorothy A, Gidding, Heather F, Nicholson, Suellen, O’Sullivan, Matthew V N, Carlin, John B, Downes, Marnie, Armstrong, Lucy, Beard, Frank H, Dwyer, Dominic E, Gibb, Robert, Gosbell, Iain B, Hendry, Alexandra J, Higgins, Geoff, Hirani, Rena, Hueston, Linda, Irving, David O, Quinn, Helen E, Shilling, Hannah, Smith, David, Kaldor, John M, Macartney, Kristine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842318/ https://www.ncbi.nlm.nih.gov/pubmed/35169588 http://dx.doi.org/10.1093/ofid/ofac002 |
Ejemplares similares
-
Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020
por: Machalek, Dorothy A., et al.
Publicado: (2022) -
The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021
por: Koirala, Archana, et al.
Publicado: (2022) -
SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers
por: Hasan, Tasnim, et al.
Publicado: (2021) -
“No jab, no pay”: catch‐up vaccination activity during its first two years
por: Hull, Brynley P, et al.
Publicado: (2020) -
The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis
por: Hasan, Tasnim, et al.
Publicado: (2021)